Bachem Holding AG Logo

Bachem Holding AG

A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.

BANB | SW

Overview

Corporate Details

ISIN(s):
CH1176493729
LEI:
506700S81111XI7TG884
Country:
Switzerland
Address:
Hauptstrasse 144, 4416 Bubendorf
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bachem Holding AG is a leading, technology-driven biochemical company specializing in the development and manufacture of peptides and oligonucleotides. With over 50 years of experience, the company operates as a Contract Development and Manufacturing Organization (CDMO), providing a comprehensive portfolio of products and services to the global pharmaceutical and biotechnology industries. Bachem supports its clients throughout the entire lifecycle of their products, from research and clinical development to the large-scale commercial production of complex organic molecules and Active Pharmaceutical Ingredients (APIs).

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-20 02:00
Board/Management Information
Bachem expands Corporate Executive Committee to include Chief Operations Office…
English 5.3 KB
2025-08-20 02:00
Board/Management Information
Bachem erweitert Konzernleitung um die Rolle des Chief Operations Officer
German 5.8 KB
2025-07-24 02:00
Earnings Release
Bachem shows strong growth in the first half of 2025
English 10.8 KB
2025-07-24 02:00
Earnings Release
Bachem mit starkem Wachstum im ersten Halbjahr 2025
German 12.1 KB
2025-06-03 02:00
Regulatory News Service
Bachem mourns the loss of company founder Dr. h.c. Peter Grogg
English 4.7 KB
2025-06-03 02:00
Board/Management Information
Bachem trauert um Firmengründer Dr. h.c. Peter Grogg
German 7.7 KB
2025-02-27 01:00
Earnings Release
Bachem increases sales and profitability
English 9.7 KB
2025-02-27 01:00
Earnings Release
Bachem erhöht Umsatz und Profitabilität
German 11.3 KB
2024-07-25 02:00
Report Publication Announcement
Bachem with slight sales growth in the first half of 2024. Outlook confirmed fo…
English 7.9 KB
2024-07-25 02:00
Report Publication Announcement
Bachem mit leichtem Umsatzplus im ersten Halbjahr 2024. Ausblick für das Gesam…
German 8.5 KB
2024-05-28 02:00
Legal Proceedings Report
Incident on construction site of Bachem in Bubendorf
English 2.9 KB
2024-05-28 02:00
Legal Proceedings Report
Vorfall auf Baustelle der Bachem in Bubendorf
German 3.1 KB
2024-04-24 02:00
Post-Annual General Meeting Information
Bachem Annual General Meeting 2024
English 3.8 KB
2024-04-24 02:00
Post-Annual General Meeting Information
Bachem - Ordentliche Generalversammlung 2024
German 4.1 KB
2024-03-07 01:00
Earnings Release
Bachem continues to grow and increases dividend
English 9.7 KB

Automate Your Workflow. Get a real-time feed of all Bachem Holding AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bachem Holding AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bachem Holding AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-05-06 N/A Non-Executive member Buy None 30,315.25 CHF

Peer Companies

Company Country Ticker View
Newbury Pharmaceuticals AB Logo
Develops specialty prescription drugs for Scandinavia in oncology, rare diseases & neurology.
Sweden NEWBRY
New Nordic Healthbrands AB Logo
Develops and markets herbal supplements & beauty products for natural wellness consumers globally.
Sweden NNH
Newron Pharmaceuticals S.p.A. Logo
Biopharma developing novel therapies for nervous system diseases like Parkinson's and schizophrenia.
Italy NWRN
NextCell Pharma AB Logo
Develops off-the-shelf cell therapies for autoimmune diseases like type 1 diabetes.
Sweden NXTCL
NGeneBio Co., Ltd. Logo
Provides NGS-based diagnostics, software, and liquid biopsy for precision oncology and healthcare.
South Korea 354200
NIBEC CO., LTD. Logo
Biotech CDMO creating regenerative products with peptide and biomaterial technologies.
South Korea 138610
NIPPON CHEMIPHAR CO., LTD. Logo
Develops generic drugs, allergy treatments, and novel pharmaceuticals for a global market.
Japan 4539
Nippon Shinyaku Co.,Ltd. Logo
Develops pharmaceuticals and functional foods to improve healthcare and wellbeing.
Japan 4516
NKMAX Co., Ltd. Logo
Biotech firm for NK cell therapies, global research reagents, diagnostics, and supplements.
South Korea 182400
Novacyt Logo
Designs and supplies molecular diagnostic tests and PCR kits for human, veterinary, and food safety.
France ALNOV

Talk to a Data Expert

Have a question? We'll get back to you promptly.